Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Oxigene expands ophthalmology R&D program

Dec. 17, 2003

No Comments

Inhibition of factor 5A1 reduces apoptosis caused by TNF-alpha

Dec. 16, 2003

No Comments

National Eye Institute supports Genvec PEDF work through SBIR grants

Dec. 15, 2003

No Comments

Allergan and Inspire sign copromotion agreement for Elestat

Dec. 11, 2003

No Comments

Clinical trials confirm the good safety profile of anecorvate acetate

Dec. 3, 2003

No Comments

New calpain inhibitors, their preparation and use, reported by Senju team

Nov. 26, 2003

No Comments

DES may facilitate repair of damaged nerve cells

Nov. 19, 2003

No Comments

Two phase III studies for Retaane planned for January

Nov. 18, 2003

No Comments

Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy

Nov. 14, 2003

No Comments

Lexicon moves into ophthalmology

Nov. 11, 2003

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Ocular
RSS

Oxigene expands ophthalmology R&D program

Inhibition of factor 5A1 reduces apoptosis caused by TNF-alpha

National Eye Institute supports Genvec PEDF work through SBIR grants

Allergan and Inspire sign copromotion agreement for Elestat

Clinical trials confirm the good safety profile of anecorvate acetate

New calpain inhibitors, their preparation and use, reported by Senju team

DES may facilitate repair of damaged nerve cells

Two phase III studies for Retaane planned for January

Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy

Lexicon moves into ophthalmology

Today's news in brief

Today's news in brief

STAT6 stat sig? Kaken, J&J $1.2B-plus deal adds oomph to space

GLP-1 receptor agonists continue their global victory tour

AI drives financings, approvals for APAC med-tech in 2024

Ocular RSS

Ocular
RSS